Michael Ahdoot

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study”.

Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study

European Urology Oncology(2021)10.1016/j.euo.2021.03.004

N/A

2.9DataRank · unranked

50 citations

Amir H. Lebastchi, Lori Long, Andrew R. Wilbur, Patrick T. Gomella, Sherif Mehralivand +17 more

Targeting the PRC2-dependent epigenetic program alleviates urinary tract infections

iScience(2023)10.1016/j.isci.2023.106925

N/A

0.165DataRank · unranked

2 citations

Mingyi Zhao, Xinbing Sui, Zarine R. Balsara, Songhui Zhai, Michael Ahdoot +5 more

Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer

The Journal of Urology(2020)10.1097/ju.0000000000001547

N/A

0DataRank · unranked

12 citations

Lori Long, Luke O’Connor, Alex Z. Wang, Michael Ahdoot, Amir H. Lebastchi +13 more

Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance

European Urology Oncology(2020)10.1016/j.euo.2020.09.004

N/A

0DataRank · unranked

28 citations

Alex Z. Wang, Nitin Yerram, Lori Long, Michael Ahdoot, Amir H. Lebastchi +12 more

Combined MRI-targeted Plus Systematic Confirmatory Biopsy Improves Risk Stratification for Patients Enrolling on Active Surveillance for Prostate Cancer

Urology(2020)10.1016/j.urology.2020.06.061

N/A

0DataRank · unranked

6 citations

Alex Z. Wang, Nitin Yerram, Amir H. Lebastchi, Michael Ahdoot, Sandeep Gurram +10 more

Pathologic outcomes of MRI invisible tumors in prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.282

N/A

0DataRank · unranked

0 citations

Amir H. Lebastchi, Michael Ahdoot, Alex Z. Wang, Bradford J. Wood, Barış Türkbey +2 more

Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?

The Journal of Urology(2021)10.1097/ju.0000000000002182

N/A

0DataRank · unranked

55 citations

Michael Ahdoot, Michael Daneshvar, Christian Hague, Andrew R. Wilbur, Patrick T. Gomella +13 more

MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up

Diagnostic and Interventional Radiology(2021)10.5152/dir.2021.20095

N/A

0DataRank · unranked

26 citations

Arvin K. George, Anthony Hoang, Houston Metro Urology, Houston, Texas, USA, Soroush Rais‐Bahrami, Ardeshir R. Rastinehad +12 more

Reoperative Partial Nephrectomy—Does Previous Surgical Footprint Impact Outcomes?

The Journal of Urology(2021)10.1097/ju.0000000000001837

N/A

0DataRank · unranked

17 citations

Nicholas A. Friedberg, Chirag Gordhan, Winston Li, Michael Ahdoot, Jillian Egan +6 more

Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer

The Journal of Urology(2021)10.1097/ju.0000000000002343

N/A

0DataRank · unranked

8 citations

Nitin Yerram, Luke O’Connor, Wayne Brisbane, Vidit Sharma, Ryan Chuang +19 more

Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.02.018

N/A

0DataRank · unranked

12 citations

Michael Daneshvar, Amir H. Lebastchi, Michael Ahdoot, Samuel Gold, Graham Hale +10 more

Identifying novel biomarkers associated with bladder cancer treatment outcomes

Frontiers in Oncology(2023)10.3389/fonc.2023.1114203

N/A

0DataRank · unranked

30 citations

Dan Theodorescu, Charles J. Rosser, Michael Ahdoot, Peris Castaneda

Timing, incidence and management of delayed bleeding after partial nephrectomy in patients at risk for recurrent, bilateral, multifocal renal tumors

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.03.004

N/A

0DataRank · unranked

7 citations

Julie Solomon, Michael Ahdoot, Sandeep Gurram, Amir H. Lebastchi, Elliot Levy +7 more

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

New England Journal of Medicine(2020)10.1056/nejmoa1910038

N/A

0DataRank · unranked

892 citations

Andrew R. Wilbur, Sarah E. Reese, Amir H. Lebastchi, Sherif Mehralivand, Patrick T. Gomella +13 more

Renal Function After Partial Nephrectomy: A Comparative Analysis of Warm, Cold, and No Ischemia Methods

Urology Practice(2025)10.1097/upj.0000000000000779

N/A

0DataRank · unranked

3 citations

Jillian Egan, Maria Antony, Michael Ahdoot, Nitin Yerram, Amir H. Lebastchi +7 more

PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance

The Journal of Urology(2020)10.1097/ju.0000000000001307

N/A

0DataRank · unranked

18 citations

Luke P. Oonnor, Nitin Yerram, Lori Long, Johnathan Zeng, Sherif Mehralivand +12 more